US Patent 12077758 Oligonucleotides for SARS-CoV-2 modulation
Patent 12077758 was granted and assigned to University of Massachusetts on September, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+44 properties)
Article (+184 characters)
US Patent 12077758 Oligonucleotides for SARS-CoV-2 modulation
Article
Patent abstract
This disclosure relates to novel SARS-CoV-2 targeting sequences. Novel SARS-CoV-2 targeting oligonucleotides for the treatment of SARS-CoV-2 infection are also provided.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Anastasia Khvorova1
Annabelle Biscans1
Bruno Miguel da Cruz Godinho1
Chantal Ferguson1
Daniel O′Reilly1
Dimas Echeverria Moreno1
Gitali Devi1
Jacquelyn Sousa1
Jillian Caiazzi1
Jonathan Watts1
Kathryn Monopoli1
Ken Yamada1
Minwook Shin1
Nicholas McHugh1
Pranathi Meda Krishnamurthy1
Qi Tang1
Samuel Hildebrand1
Sarah Davis1
Socheata Ly1
Vignesh Narayan Hariharan1
Yann Thillier1
Zachary Kennedy1
Date of Patent
September 3, 2024
1Patent Application Number
173338391
Date Filed
May 28, 2021
1Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12077758 Oligonucleotides for SARS-CoV-2 modulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
- Create Issue
- View Changes
- Content Issue